Long-Term Safety and Efficacy of Add-on Cannabidiol (CBD) Treatment in Patients with Dravet Syndrome (DS) in an Open-Label Extension (OLE) Trial-MedSci.cn

Long-Term Safety and Efficacy of Add-on Cannabidiol (CBD) Treatment in Patients with Dravet Syndrome (DS) in an Open-Label Extension (OLE) Trial

Shiloh-Malawsky, Y; Scheffer, I; Halford, J; Nabbout, R; Sanchez-Carpintero, R; Wong, M; Checketts, D; VanLandingham, K

ANNALS OF NEUROLOGY, 2019; 86 (): S71

科室
- - 订阅+
  - 更多科室
工具
服务